IBM shares experienced a significant surge following the announcement of a landmark quantum computing achievement in partnership with global banking giant HSBC. The collaboration has successfully demonstrated that quantum technology can deliver tangible benefits in real-world financial applications, a goal that has long been considered theoretical.
Solid Fundamentals Underpin Technological Advance
Beyond the quantum computing news, the positive investor sentiment is supported by strong fundamental performance. IBM recently reported quarterly earnings that surpassed market expectations, with revenue climbing 7.7% compared to the same period last year. The company’s strategic pivot toward higher-margin segments—including software, artificial intelligence, and hybrid-cloud solutions—is yielding clear results and establishing a durable foundation for continued expansion.
Should investors sell immediately? Or is it worth buying IBM?
A Practical Milestone for Quantum Technology
The core of the breakthrough lies in a successful experiment using IBM’s “Heron” quantum processor. The technology demonstrated a measurable improvement in forecasting accuracy for trade execution within the European corporate bond market. Specifically, the application of quantum computing increased the probability of executing client orders profitably by up to 34% over conventional methods. This result provides the first concrete evidence of a practical “quantum advantage” in the field of algorithmic trading, marking a critical milestone for the entire industry.
The combination of pioneering technological innovation and sound financial health is positioning IBM as an increasingly compelling opportunity for investors. A key question now is whether this renewed momentum can propel the stock toward its 52-week high of approximately 255 euros.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from September 27 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 27.
IBM: Buy or sell? Read more here...